Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study
Information source: Centre Hospitalier Universitaire de Nice
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Rheumatoid Arthritis
Intervention: intra-articular injection of etanercept (Procedure); intra-articular injection of steroid (Procedure)
Phase: Phase 3
Status: Completed
Sponsored by: Centre Hospitalier Universitaire de Nice Official(s) and/or principal investigator(s):
Christian H ROUX, Principal Investigator, Affiliation: Rheumatology department, Nice
Summary
Intra-articular injection of etanercept in patient suffering from rheumatoid arthritis: a
double-blind randomized study for evaluation of efficacy and safety of etanercept versus
intra-articular steroid injection in acute synovitis (knee,wrist,ankle,elbow)
Clinical Details
Official title: Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study for Evaluation of Efficacy and Safety of Etanercept Versus Intra-Articular Steroid Injection in Acute Synovitis
Study design: Treatment, Randomized, Double Blind (Subject, Investigator), Active Control, Parallel Assignment, Safety/Efficacy Study
Primary outcome: Pain
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- must be able to understand the information about the study
- diagnosis of rheumatoid arthritis for 6 month at least
- suffering for 2 weeks at least
- with evaluation of pain over 4/10
- with stable DMARDs treatment for three month at least
Exclusion Criteria:
- infection or surgery on the target joint
- treated with infliximab,adalimumab or anakinra
Locations and Contacts
Rheumatology department, Hopital Archet I, NICE 06000, France
Additional Information
Starting date: February 2005
Ending date: November 2006
Last updated: August 27, 2007
|
